Old Web
English
Sign In
Acemap
>
authorDetail
>
John M. Goldman
John M. Goldman
Oregon Health & Science University
Internal medicine
Medicine
Oncology
Imatinib
Myelogenous
3
Papers
166
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Myelogenous Leukemia Busulfan Alone as Cytoreduction Before Autografting for Chronic
2010
Stephen G. O’Brien
John M. Goldman
Show All
Source
Cite
Save
Citations (0)
International Randomized Study of Interferon Versus STI571 (IRIS) 7-Year Follow-up: Sustained Survival, Low Rate of Transformation and Increased Rate of Major Molecular Response (MMR) in Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CMLCP) Treated with Imatinib (IM)
2008
Blood
Stephen G. O’Brien
F. Guilhot
John M. Goldman
A. Hochhaus
Timothy P Hughes
Jerald P. Radich
Marc Rudoltz
Jeiry Filian
Insa Gathmann
Brian J. Druker
R. A. Larson
Show All
Source
Cite
Save
Citations (166)
Imatinib: Profile report
2002
Drugs & Therapy Perspectives
John M. Goldman
Brian J. Druker
Show All
Source
Cite
Save
Citations (0)
1